Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 (ND4)

Target
ND4
Molecular classification
Enzyme subunit, Transmembrane protein, Minimal assembly core protein of complex I
01

Overview

ND4 (NADH:ubiquinone oxidoreductase core subunit 4) is a mitochondrially encoded, hydrophobic transmembrane subunit of complex I. This multiprotein complex is the largest of the respiratory chain components and initiates electron transport by transferring electrons from NADH to ubiquinone, which supports proton translocation and ultimately ATP production. ND4 forms part of the membrane arm essential for proper complex I assembly and function. Dysfunction or mutations of ND4 are linked to mitochondrial diseases, particularly Leber hereditary optic neuropathy, and may contribute to other neuromuscular and neurodegenerative conditions. While specific pharmacological direct targeting is rare, research into gene therapy is ongoing for ND4-related disease.

Other names
MT-ND4complex I ND4 subunitNADH-ubiquinone oxidoreductase chain 4
02

Mechanism of action

Drugs or gene therapies act by: Modulating NADH:ubiquinone oxidoreductase activity (enzyme function); Restoring or replacing defective ND4 (gene therapy for inherited defects)

03

Biological functions

Electron transportProton translocationATP synthesisEnergy metabolism
04

Disease associations

Leber hereditary optic neuropathyNeurodegenerative diseaseOther mitochondrial diseases
05

Safety considerations

Off-target mitochondrial dysfunctionPotential toxicity and energy failure in high metabolic demand tissues (heart, brain, retina)Limited targeting of mitochondria by systemic drugs
06

Interacting drugs

No specific approved drugs are known to directly target ND4

2 more in the full profile.

07

Biomarkers

MT-ND4 mutation detectionComplex I activity assays

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 (ND4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 (ND4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call